Moreover, in-vivo study found that PTGDS deficiency promoted the growth of melanoma through accelerating vascular hyperpermeability, angiogenesis, and endothelial-to-mesenchymal transition, which could be reversed by PGD2 receptor agonist [30]. This evidence concerns the gene PTGDS and melanoma.